ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Dawnrays Pharmaceutical Holdings Ltd. ?
1
High Management Efficiency with a high ROE of 12.81%
2
Company has very low debt and has enough cash to service the debt requirements
3
Poor long term growth as Operating profit has grown by an annual rate -13.14% of over the last 5 years
4
Flat results in Dec 25
- OPERATING CASH FLOW(Y) Lowest at HKD 711.47 MM
- DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
- RAW MATERIAL COST(Y) Grown by 13.49% (YoY)
5
With ROE of 5.17%, it has a Very Attractive valuation with a 0.48 Price to Book Value
- Over the past year, while the stock has generated a return of -6.72%, its profits have fallen by -69%
6
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -6.72% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Dawnrays Pharmaceutical Holdings Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Dawnrays Pharmaceutical Holdings Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Dawnrays Pharmaceutical Holdings Ltd.
-6.72%
-0.29
20.32%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.71%
EBIT Growth (5y)
-13.14%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.40
Sales to Capital Employed (avg)
0.42
Tax Ratio
11.58%
Dividend Payout Ratio
40.80%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.00%
ROE (avg)
12.81%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.48
EV to EBIT
1.13
EV to EBITDA
0.74
EV to Capital Employed
0.10
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.66%
ROE (Latest)
5.17%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
CASH AND EQV(HY)
Highest at HKD 1,756.4 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -44.3 %
INVENTORY TURNOVER RATIO(HY)
Highest at 2.47 times
DEBTORS TURNOVER RATIO(HY)
Highest at 4.6 times
NET SALES(Q)
At HKD 657.34 MM has Grown at 25.49%
PRE-TAX PROFIT(Q)
At HKD 154.68 MM has Grown at 82.63%
NET PROFIT(Q)
At HKD 141.84 MM has Grown at 86.77%
-5What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at HKD 711.47 MM
DIVIDEND PAYOUT RATIO(Y)
Lowest at 0%
RAW MATERIAL COST(Y)
Grown by 13.49% (YoY
DIVIDEND PER SHARE(HY)
Lowest at HKD 4.6
Here's what is working for Dawnrays Pharmaceutical Holdings Ltd.
Net Sales
At HKD 657.34 MM has Grown at 25.49%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Pre-Tax Profit
At HKD 154.68 MM has Grown at 82.63%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 141.84 MM has Grown at 86.77%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Cash and Eqv
Highest at HKD 1,756.4 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -44.3 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2.47 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 4.6 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at HKD 77.11 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 77.11 MM has Grown at 44.75%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Dawnrays Pharmaceutical Holdings Ltd.
Operating Cash Flow
Lowest at HKD 711.47 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Dividend per share
Lowest at HKD 4.6
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (HKD)
Dividend Payout Ratio
Lowest at 0%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Grown by 13.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
